Compare MasterCard Inc (MA) vs Nuvation Bio Inc. Class A Common Stock (NUVB) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
MasterCard Inc vs Nuvation Bio Inc. Class A Common Stock — how do they compare? MasterCard Inc trades at $574.4 (market cap $499.38B), while Nuvation Bio Inc. Class A Common Stock trades at $4.95 (market cap $1.71B). The key difference: MasterCard Inc is far larger — about 292× Nuvation Bio Inc. Class A Common Stock's market cap, and MasterCard Inc pays a 0.61% dividend while Nuvation Bio Inc. Class A Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold MasterCard Inc for 134 Days and Nuvation Bio Inc. Class A Common Stock for 0 Days on average.
| MA | NUVB | |
|---|---|---|
Market Cap | $499.38B | $1.71B |
Volume | 1,862,680 | 5,448,712 |
Sector | Financials | Health |
52-Week High | $599.86 | $9.54 |
52-Week Low | $471.55 | $3.41 |
Typical Hold Time | 134 Days | 0 Days |
Enterprise Value | $512.41B | $1.30B |
Dividend Yield | 0.61% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Mastercard (MA) trades at $570.06, up 0.61% with a bullish technical signal and strong institutional interest. The company demonstrates robust fundamentals with 2025 revenue of $32.79B and net income of $14.97B, maintaining exceptional profitability margins. Recent earnings have consistently beaten expectations, with Q2 2026 EPS of $5.04 surpassing the $4.77 estimate. Analyst consensus remains strongly positive with 80% buy ratings and a $666.67 price target, representing 17% upside potential from current levels.
Mastercard presents a compelling growth opportunity with expanding digital payments adoption and strong execution, though faces risks from payment industry disruption and competitive threats. The stock's premium valuation (P/E 31.36) reflects high growth expectations that must be sustained. Near-term catalysts include Q3 2026 earnings and continued AI payment innovation, while regulatory scrutiny and economic sensitivity remain key monitoring points for investors.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About MasterCard Inc
Mastercard Incorporated provides financial transaction processing services. The Company offers payment processing services for credit and debit cards, electronic cash, automated teller machines, and travelers checks. Mastercard serves customers worldwide.
Read more on MA →About Nuvation Bio Inc. Class A Common Stock
Nuvation Bio Inc. is a biopharmaceutical company focused on oncology, developing novel cancer treatments including taletrectinib (marketed as IBTROZI), a ROS1 inhibitor, and safusidenib, a brain-penetrant IDH1 inhibitor.
Read more on NUVB →
